Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15284747 | 1.00 | KMT2A (0.30) | KMT2A | |
| SCHEMBL8520957 | 1.00 | KMT2A (0.30) | KMT2A | |
| SCHEMBL3345612 | 0.97 | — | — | |
| SCHEMBL27734262 | 0.90 | — | — | |
| Phosphoric Acid SCHEMBL7110419 | 0.89 | MMP2 (0.31) | — | |
| Phosphoric Acid SCHEMBL7113455 | 0.89 | MMP2 (0.31) | — | |
| SCHEMBL15984941 | 0.87 | — | — | |
| SCHEMBL27519737 | 0.81 | ACHE (0.30) | — | |
| SCHEMBL3376140 | 0.78 | — | — | |
| SCHEMBL27858222 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1223342-C | Sucros ester-C20-28 alcohol preparation | AVENNIL MEDICINE INC (US) | 2005-10-19 | — | — | CN | claimed |
| CN-1419911-A | Sucros ester-C20-28 alcohol preparation | AVENNIL MEDICINE INC (US) | 2003-05-28 | — | — | CN | claimed |
| CN-1103586-C | Sucrose ester-C20-28 alcohol formulations | LIDAK PHARMACEUTICALS (US) | 2003-03-26 | — | — | CN | claimed |
| CN-1142764-A | Sucrose ester-C20-28Alcohol formulations | LIDAK PHARMACEUTICALS (US) | 1997-02-12 | — | — | CN | claimed |
| WO-2019072353-A1 | TOPICAL PHARMACEUTICAL PREPARATION OF BETAMETHASONE, CALCIPOTRIOL AND ROSE OIL FOR TREATMENT OF PSORIASIS | ELMASRY MOHAMED ZAKRIA AHMED ALI (EG) | 2019-04-18 | — | — | WO | disclosed |
| US-20150274972-A1 | ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING | ALZO INTERNATIONAL, INC. (US) | 2015-10-01 | — | — | US | disclosed |
| EP-2906614-A1 | ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING | Alzo International, Inc. (US) | 2015-08-19 | — | — | EP | disclosed |
| US-20130109889-A1 | LUBRICANT BASE OIL FOR HYDROCARBON REFRIGERANT AND LUBRICATING OIL COMPOSITION COMPRISING IT | ASAHI GLASS COMPANY, LIMITED (JP) | 2013-05-02 | — | — | US | disclosed |
| EP-2586853-A1 | LUBRICATING OIL BASE OIL FOR HYDROCARBON REFRIGERANT AND LUBRICATING OIL COMPOSITION COMPRISING SAME | Asahi Glass Company, Limited (JP) | 2013-05-01 | — | — | EP | disclosed |
| EP-2484819-A2 | MARINE POLYESTER FIBER, AND PREPARATION METHOD THEREOF | Kolon Industries, Inc. (KR) | 2012-08-08 | — | — | EP | disclosed |
| US-20120189847-A1 | MARINE POLYESTER YARN AND PREPARATION METHOD THEREOF | KOLON INDUSTRIES, INC. (KR) | 2012-07-26 | — | — | US | disclosed |
| EP-1466582-B1 | Hair treatment agent comprising a silylated peptide-silane copolymer | SEIWA KASEI CO LTD (JP) | 2009-07-29 | — | — | EP | disclosed |
| EP-0403530-A4 | STORAGE-STABLE COMPOSITIONS AND METHODS FOR TREATING KERATINOUS TISSUE | — | 1991-09-11 | — | — | EP | disclosed |
| US-5047249-A | Protein containing cysteinyl group, reducing agent, and oxidizing agent | JOHN MORRIS CO., INC. (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0425507-A4 | COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS AND PROMOTING WOUND HEALING | — | 1991-07-03 | — | — | EP | disclosed |
| EP-0425507-A1 | COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS AND PROMOTING WOUND HEALING. | CIRO S TOUCH LTD (US) | 1991-05-08 | — | — | EP | disclosed |
| WO-1991002538-A1 | ODOR-MASKED AND STABILIZED COMPOSITIONS FOR TREATING KERATINOUS TISSUE, SKIN CONDITIONS, AND PROMOTING WOUND HEALING | JOHN MORRIS CO., INC. (US) | 1991-03-07 | — | — | WO | disclosed |
| EP-0403530-A1 | STORAGE-STABLE COMPOSITIONS AND METHODS FOR TREATING KERATINOUS TISSUE | CIRO'S TOUCH, LTD. (US) | 1990-12-27 | — | — | EP | disclosed |
| WO-1990000899-A1 | COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS AND PROMOTING WOUND HEALING | CIRO'S TOUCH, LTD. (US) | 1990-02-08 | — | — | WO | disclosed |
| WO-1989007930-A1 | STORAGE-STABLE COMPOSITIONS AND METHODS FOR TREATING KERATINOUS TISSUE | CIRO'S TOUCH, LTD. (US) | 1989-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150274972-A1 | ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING | CUTA, TRRAP, LCP1 | KMT2A 1228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.